Tango Therapeutics (TNGX) Net Margin (2020 - 2025)
Tango Therapeutics (TNGX) posted quarterly Net Margin of 29.52% for Q3 2025, up 28081.0% year-over-year from N/an in Q3 2024, and up 102.42% quarter-over-quarter from 1221.41% in Q2 2025.
Tango Therapeutics (TNGX) Net Margin (2020 - 2025) Analysis & Trends
Tango Therapeutics' Net Margin history runs 6 years deep, the most recent figure standing at 29.52% for Q3 2025.
- In Q3 2025, Net Margin rose 28081.0% year-over-year to 29.52%; the TTM figure through Mar 2026 stood at 188.15% (up 13451.0% YoY), while the FY2025 annual figure was 162.85%, up 14688.0% from the prior year.
- Net Margin for Q3 2025 stood at 29.52%, up from 1221.41% in the prior quarter.
- The five-year high for Net Margin was 29.52% in Q3 2025, with the low at 1221.41% in Q2 2025.
- The 5-year median for Net Margin is 419.8% (2022), against an average of 412.86%.
- The sharpest annual moves came in 2023 and 2025: Net Margin soared 28862 bps in 2023, then tumbled 109285 bps in 2025.
- Tango Therapeutics' Net Margin stood at 385.69% in 2021, then slipped by 18 bps to 454.0% in 2022, then declined by 25 bps to 565.81% in 2023, then sank by 62 bps to 914.99% in 2024, then soared by 103 bps to 29.52% in 2025.
- Business Quant data shows TNGX's Net Margin at 29.52% in Q3 2025, 1221.41% in Q2 2025, and 739.54% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 30.33% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.90% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 30.98% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 12.09% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 12.74% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -3.12% |
| 10 | Tango Therapeutics | 4.32 Bn | 3.30 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 29.52% |
| Jun 30, 2025 | -1,221.41% |
| Mar 31, 2025 | -739.54% |
| Dec 31, 2024 | -914.99% |
| Sep 30, 2024 | -251.29% |
| Jun 30, 2024 | -128.56% |
| Mar 31, 2024 | -585.91% |
| Dec 31, 2023 | -565.81% |
| Sep 30, 2023 | -207.45% |
| Jun 30, 2023 | -142.12% |
| Mar 31, 2023 | -485.74% |
| Dec 31, 2022 | -454.00% |
| Sep 30, 2022 | -419.80% |
| Jun 30, 2022 | -430.74% |
| Mar 31, 2022 | -437.79% |
| Dec 31, 2021 | -385.69% |
| Sep 30, 2021 | -288.64% |
| Jun 30, 2021 | -24.75% |
| Mar 31, 2021 | -189.57% |
| Dec 31, 2020 | -1.99% |